<DOC>
	<DOCNO>NCT01281345</DOCNO>
	<brief_summary>Title : A multicenter observational study candidemia case among ICU patient India Objective : Primary objective : Determine epidemiological also clinical parameter candidemia case among ICU patient India . Exploratory Objectives : 1 . Determine prevalence candidemia among ICU patient . 2 . Determine prevalence candidemia due C. albicans species non-albicans Candida specie . 3 . Determine demographic risk factor candidemia patient comparison relevant variable case C. albicans non-albicans Candida specie isolation . 4 . Describe physician practice management candidemia case - clinical outcome . 5 . Determine in-vitro antifungal susceptibility Candida isolates . Study description purpose : Short description : Observational multicentre study ICU patient . Study purpose : Epidemiological determinant candidemia , management outcome evaluation . How study would help ? It would help evaluate outcome current management strategy develop future well management strategy candidemia case . Critical issue &amp; risk : Site &amp; center selection would important No risk patient include study observational study Study design : Site selection : A questionnaire circulate ( annexure I ) major tertiary care center India . The center select competence candidemia diagnosis availability ICU facility . Expected number center ~ 20 . Study period : October 1 , 2010 - March 31 , 2012 No patients/sites : Consecutive patient candidemia detect ICU stay study period include study site . Patient selection : Inclusion criterion : 1 . Admitted ICU &gt; 48 hour ( coincide definition nosocomial ICU-acquired ) 2 . All age group patient include ( pediatric &amp; adult ) 3 . Diagnosed proven candidemia ( isolation Candida species blood culture ≥ 1 occasion ICU stay ) 4 . Blood culture positive Candida spp . , sample drawn within 48 hrs discharge ICU . Exclusion criterion : 1 . Patient already diagnose candidemia admission ICU Variables| : type ICU , demographic data patient , underlie illness , risk factor , severity score , diagnostic method , treatment characteristic ( Annexure II ) treatment outcome ( Annexure III ) Diagnosis candidemia : Isolation Candida species blood culture ( arterial/venous ) method ( conventional/ lysis-centrifugation/ automate system/ method ) . No intervention diagnostic process center . Centers perform diagnosis candidemia exclude study Data recording : manual online . The form Annexure II fill within 5 day diagnosis candidemia ; Annexure III fill within 7 day discharge hospital 30 day start antifungal therapy death patient ( period early ) . Data analysis : appropriate statistical method employ analysis data .</brief_summary>
	<brief_title>SIHAM Candidemia Network : An Observational Study</brief_title>
	<detailed_description>1 . Objectives : 1.1 . Primary objective : Determine epidemiological parameter candidemia case among ICU patient India 1.2 . Exploratory objective 1 . Determine prevalence candidemia among ICU patient . 2 . Determine prevalence candidemia due C. albicans species non-albicans Candida specie . 3 . Determine demographic risk factor candidemia patient , comparison relevant variable case C. albicans non-albicans Candida specie isolation . 4 . Describe management candidemia case outcome . 5 . Determine in-vitro antifungal susceptibility test Candida isolates . 2 . Study description purpose : 2.1 Observational multicentre study ICUs India . Institute ICUs facility diagnosis candidemia choose . 2.2 Purpose : Determination epidemiological parameter candidemia , description current management outcome patient candidemia . This would help formulation guideline management patient candidemia especially patient critically ill admit ICUs . 2.3 Critical issue &amp; risk : There risk patient observational study intervention intend . The site selection would important get useful data . 3 . Study design : 3.1 Site selection : The major tertiary care center evaluate basis response set questionnaire ( Annexure I ) . Only center ICU facility competence diagnose candidemia select . Expected number center ~20 . 3.2 Study period : October 1 , 2010 - March 31 , 2012 3.3 No patient : Consecutive patient candidemia diagnosed ICUs &gt; 48 h admission study period include site . Expected number patient candidemia would ~2000 4 . Patient selection : 4.1 Inclusion criterion : 1 . Admitted ICUs &gt; 48 hour 2 . All age group patient include ( adult &amp; child ) 3 . Diagnosed proven candidemia isolation Candida species ≥1 occasion blood ICU stay . 4 . Blood culture positive Candida spp . , sample drawn within 48 hrs discharge ICU . 4.2 Exclusion criterion : ) Patient already diagnose candidemia admission ICUs ICU ≤48h . 5 . Patient management : During study period , process patient management include diagnosis treatment determine treat physician . There intervention patient management part study related activity . 6 . Conduct study 6.1 Investigators study - The ICU specialist charge microbiologist/mycologist center site investigator study . Prof. Arunaloke Chakrabarti PGIMER , Chandigarh coordinator study . A/Prof . Sharon Chen , Medical Mycologist , Infectious Diseases Microbiology , Westmead Hospital , Australia advisor study . 6.2 Patient enrollment - The investigator ensure patient candidemia development ICU ( see inclusion criterion ) include . Consecutively patient meet eligibility criterion consecutively enrol . The patient enrol prospectively soon diagnosis confirm . The patient follow till discharge hospital 30 day start antifungal therapy death ( whichever earlier ) . 6.3 Data collection - The form ( Annexure II ) fill within 5 day diagnosis candidemia . The investigator would make sure patient identify ( No mention patient 's name , address , hospital registration . laboratory . survey form ) . The data collection perform line hard copy . The follow variable note : 1 . Demographic data 2 . Evaluation severity patient ( severity assess basis score system available hospital ( e.g , APACHE , SOFA ) . 3 . Underlying disease 4 . Risk factor 5 . History previous antifungal therapy ( prophylaxis/empiric/ definitive treatment ) 6 . Description candidemia episode 7 . Laboratory result 8 . Diagnosis candidemia . 6.4 Laboratory mycological test - No laboratory microbiological test mandatory patient part study . Study protocol intervene anywhere laboratory investigation patient . Data laboratory test perform part routine collect study case form 6.5 Patient management : The study intervene anywhere patient management . The clinician charge manage patient . The data management practice incorporate retrospectively management form ( Annexure III ) within 7 day patient 's discharge hospital 30 day start antifungal therapy patient 's death ( whichever earlier ) 6.6 Identification Candida isolate antifungal susceptibility testing : Candida isolates may identify antifungal susceptibility testing may perform study center part center 's routine procedure . However , Candida isolate ( isolated blood ) submit reference laboratory Postgraduate Institute Medical Education Research ( PGIMER ) , Chandigarh fill form IV . PGIMER , Chandigarh confirm identity Candida isolate perform antifungal susceptibility test accord CLSI M27-A3 protocol ( broth microdilution method ) 6.7 . Statistical analysis : Descriptive statistical method employ analyze data . 7 . Security Confidentiality Once patient deem eligible participate consent obtain ( ) , unique study number assign . Subject initial institution identification enter log book remain sole property site . The logbook keep secure site accord site 's policy procedure . The logbook assist investigator particular Institute track upload data system . Each site able view patient enter summary data aggregate patient center , data site . 8 . Publication : In event publication , Investigators ' name cite attribute large number case study . The coordinator advisor also cite . The order authorship would depend upon number case per investigator per center , decrease order . The exact number author remain decided upon , maximum number may restrict 11 . The 'SIHAM ' candidemia network mention end author . All investigator acknowledge participant network appendix . The sponsor network acknowledge publication . None sit permitted make publication sit data , base solely parameter include study case include present study , study period . If breach understanding , data centre include final data analysis . 9 . Ethical Issue : The project clear participate center respective local Ethics Committee commence project . The Ethics approval Certificate submit coordinator commence project .</detailed_description>
	<mesh_term>Candidemia</mesh_term>
	<criteria>Admitted ICUs &gt; 48 hour All age group patient include ( adult &amp; child ) Diagnosed proven candidemia isolation Candida species ≥1 occasion blood ICU stay . Blood culture positive Candida spp . , sample drawn within 48 hrs discharge ICU . Patient already diagnose candidemia admission ICUs ICU ≤48h .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>icu</keyword>
	<keyword>candida</keyword>
	<keyword>epidemiology</keyword>
	<keyword>blood stream infection</keyword>
	<keyword>candidemia</keyword>
</DOC>